MUG researchers working on breakthrough regulatory T cell (Treg) therapy

20.10.2014

foto: Sara Serritella

The University of Chicago Institute for Translational Medicine selected a joint project by the University of Chicago and the MUG as one of the most promising. The project concerns treatment of diabetes mellitus type 1 and the pancreatic islet transplantation with regulatory T cells (Tregs).

The cooperation between the two universities began in 2009 and resulted in multiple published papers, grants (e.g. National Center for Advancing Translational Sciences USA, European Cooperation in Science and Technology Action, Strategmed NCBiR) and a program focused on implementing Treg therapy in Poland and the USA.

More information at:

• sciencelife.uchospitals.edu
• sciencelife.uchospitals.edu/2014/10/15/working-to-cure-autoimmune-diseases-and-end-organ-transplant-rejection/

The research team in Chicago. From left: dr hab. Piotr Witkowski (team leader); mgr Karolina Golab (Treg project specialist); dr Sabarinathan Ramachandran (director of the islet isolation laboratories); Zehra Tekin, MD (postdoctoral research scholar); dr Omid Savari (postdoctoral research scholar); dr Randall Grose (Treg project specialist); mgr Paulina Langa (visiting PhD student from prof. Trzonkowski’s lab at the MUG). Photo by Sara Serritella.